Identification of Purple Acid Phosphatase Inhibitors by Fragment-Based Screening: Promising New Leads for Osteoporosis Therapeutics
Version of Record online: 3 SEP 2012
© 2012 John Wiley & Sons A/S
Chemical Biology & Drug Design
Volume 80, Issue 5, pages 665–674, November 2012
How to Cite
Feder, D., Hussein, W. M., Clayton, D. J., Kan, M.-W., Schenk, G., McGeary, R. P. and Guddat, L. W. (2012), Identification of Purple Acid Phosphatase Inhibitors by Fragment-Based Screening: Promising New Leads for Osteoporosis Therapeutics. Chemical Biology & Drug Design, 80: 665–674. doi: 10.1111/cbdd.12001
- Issue online: 5 OCT 2012
- Version of Record online: 3 SEP 2012
- Accepted manuscript online: 26 JUL 2012 08:41PM EST
- Received 6 March 2012, revised 16 May 2012 and accepted for publication 3 July 2012
Figure S1. Non-linear regression curve fitting for the inhibition of (a) rkbPAP and (b) pigPAP.
Table S1. Contacts (Å) between inhibitors and rkbPAP in the crystal structures.
|CBDD_12001_sm_FigS1-TableS1.docx||246K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.